• Andy Goren, MD
• ·
• 19 January 2021

JEADV Dermatology Podcast

Anti-androgens in the treatment of severe COVID-19

• Andy Goren, MD
• ·
• 7 January 2021

COVID-19 AndroCoV Protocol Pioneered by Applied Biology and Brazilian Scientists Adopted by the Brazilian Government

BREAKTHROUGH DISCOVERY BY APPLIED BIOLOGY SCIENTISTS PAVES WAY TO POTENTIALLY MORE EFFICIENT TREATMENT FOR COVID-19

• Andy Goren, MD
• ·
• 6 January 2021

Reorganização dos postos de saúde, recrutamento de médicos e abertura de novos leitos de UTI estão entre as iniciativas para enfrentamento da pandemia no município; estratégia de vacinação para o Amazonas também será apresentada

• Andy Goren, MD
• ·
• 28 November 2020

Dr. Andy Goren Presents COVID-19 Research to Brazil Minister of Science

Dr. Goren and Astronaut Marcos Pontes, State Minister of Science of Brazil, met to discuss anti-androgens as a treatment for COVID-19.

• Andy Goren, MD
• ·
• 28 September 2020

Applied Biology in Collaboration with Researchers at University Hospital Ramon y Cajal Hospital Announce Results from Study of Androgen Receptor Genetics in Hospitalized COVID-19 Patients

STUDY CONFIRMS ASSOCIATION OF ANDROGEN RECEPTOR WITH COVID-19 DISEASE SEVERITY

• Andy Goren, MD
• ·
• 22 September 2020

Applied Biology and Corpometria Institute Receive National IRB Approval to Study a Potential Breakthrough Therapy for COVID-19

NEXT GENERATION ANTI-ANDROGEN AS A POTENTIAL TREATMENT FOR COVID-19

• Andy Goren, MD
• ·
• 14 July 2020

Applied Biology and Kintor to Collaborate on the use of Proxalutamide for the Treatment of COVID-19

IN A RACE TO FIND A TREATMENT FOR COVID-19, KINTOR HAS TEAMED WITH APPLIED BIOLOGY TO STUDY ITS LEAD ANTI-ANDROGEN AGAINST COVID-19

• BBC Radio
• ·
• 6 June 2020

BBC Interview: The Possible Link Between Covid-19 and the Androgen Receptor

Listen to the Phil Kennedy interview of Professor Andy Goren and Dr. Carlos Wambier.

• The Bald Truth
• ·
• 9 June 2020

COVID-19 Symptoms Appear to be Worse in Bald Men

Watch the Spencer Kobren Interview of Applied Biology's CMO Andy Goren and Fellow Researchers.

• Dermasphere
• ·
• 6 July 2020

COVID, Androgens, Alopecia, and Sunlight

A Conversation with Carlos Wambier and Andy Goren

• Dermasphere
• ·
• 12 June 2020

Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients

Listen to Luke Johnson and Michelle Tarbox, MD on the Dermasphere Podcast (Episode 29) Discussing Applied Biology and Brown University's Covid-19 Research Article — Starting at 43:44 Timestamp.

• ABC News Australia
• ·
• 24 June 2020

Why are More Bald Men Hospitalized for Coronovirus?

The answer could point to a treament.

• Miami Herald
• ·
• 23 June 2020

Bald Men Might Have a Higher Risk of Mortality from COVID-19, Studies Say

Women's levels of androgen are lower than men's, which could explain why they don’t seem to get it as badly in some cases.

• WebMD
• ·
• 12 June 2020

Androgens are the Gateway for Coronovirus to Enter Cells

Male Baldness May Increase Severe COVID-19 Risk.

• FOX NEWS
• ·
• 12 June 2020

Bald Men May be Harder Hit By Coronovirus

Baldness May be a Perfect Predictor of Severity.

• NY POST
• ·
• 11 June 2020

Coronovirus Hits Bald Men Harder?

Scientists believe that androgens may boost the ability of coronavirus to attack cells.

• Forbes Magazine
• ·
• 6 June 2020

Coronovirus Poses a Higher Risk for Bald Men

COVID-19 research is showing that men, particularly bald men, have a worse trajectory.

• Science Magazine
• ·
• 3 June 2020

Coronovirus Hits Men More Severely, Here's Why...

Studying the link between androgens and the severity of COVID-19.

• Andy Goren, MD
• ·
• 2020

Applied Biology in Collaboration with Brown Researchers Announce the Discovery of a Possible Association Between the Genetic Cause of Hair Loss and Severity of COVID-19 Infection

Joint Research Effort Points to Possible Genetic Variation that Pre-disposes COVID-19 Patients to Develop Severe Symptoms

• John McCoy, PhD
• ·
• 2019

Identification of the Sulfotransferase Iso-Enzyme Primarily Responsible for the Bio-Activation of Topical Minoxidil

J McCoy, A Goren, T Naccarato1, M Kovacevic, M Situm, VL Skudar, T Lotti. J Biol Regul Homeost Agents

• Andy Goren, MD
• ·
• 2019

History of Vitiligo

Kovacevic Maja, Franceschi Nika, Situm Mirna, Goren Andy, Stanimirovic Andrija, Valle Yan, Lotti Torello. Springer

• Andy Goren, MD
• ·
• 2019

Platelet Rich Plasma in Androgenetic Alopecia: A Systematic Review

Lotti T., Goren A., Verner I. d’Alessio P., Franca K. J.Dermatol Ther.

• Andy Goren, MD, John McCoy, PhD
• ·
• 2019

Integrative Dermatology: The Microbiome in Hair Disorders

Goren A, Situm M, Kovacevic M, McCoy J, Lotti T. Wiley

• Andy Goren, MD
• ·
• 15 March 2018

PHASE I STUDY COMPLETE

Topical Drug for the Treatment of FPHL in Non-responders to 5% Topical Minoxidil

• Andy Goren, MD
• ·
• 5 October 2017

WCHR CONGRESS

Minoxidil Dose Response Study in Female Pattern Hair Loss Patients Determined to be Non-Responders to 5% Topical Minoxidil

• Andy Goren, MD
• ·
• 22 August 2017

EADV Congress

Minoxidil Dose Response Study in Female Pattern Hair Loss Patients Determined to be Non-Responders to 5% Topical Minoxidil

• Andy Goren, MD
• ·
• 4 June 2017

NAHRS Congress

α1-AR Agonist Induced Piloerection Protects Against the Development of Traction Alopecia

• John McCoy, PhD
• ·
• 4 May 2015

SID Congress

Novel Diagnostic Test Predicts Mean Change in Hair Counts in Female Androgenetic Alopecia Patients Treated with Topical Minoxidil